What is Balchem Corp's earnings per share (EPS)?

Balchem Corp (BCPC) reported diluted earnings per share of $4.75 for fiscal year 2025. This represents a 20.9% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Balchem Corp Financials

BCPC

Trailing 12 months to June 30, 2026

Revenue $1.1B +10.1% YoY

Net Income $164.4M +15.2% YoY

EPS (Diluted) $5.09 +16.7% YoY

Free Cash Flow Not reported for the trailing 12 months

Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Jul 31, 2026 Currency USD FYE December

Balchem Corp (BCPC) reported $1.1B in revenue over the twelve months to Jun 30, 2026, up 10.1% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI BCPC FY2025 2026-07-31

Margin expansion and cash-backed self-funding are turning modest sales growth into faster profit growth at Balchem.

From FY2022 to FY2025, debt intensity fell from 0.7x to 0.3x even as goodwill-heavy assets rose to $1.69B with $816M of goodwill, while ROA improved from 6.5% to 9.2%. That combination suggests earlier acquisition spending is being absorbed through internal earnings and cash generation rather than through a more leveraged balance sheet.

The clearest operating pattern is fixed-cost absorption: operating margin widened from 17.3% in FY2023 to 20.2% in FY2025. That happened while SG&A stayed roughly flat at about $67M in the last two years, so incremental revenue is increasingly dropping through to profit.

Cash conversion remained strong in FY2025, with operating cash flow of $217M exceeding net income of $155M. Even after a much larger buyback of $108M, liquidity stayed comfortable at a 2.1x current ratio, indicating shareholder returns were funded from operating strength rather than short-term balance-sheet strain.

Financial Health Signals

Financial Health Score 58/100

Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of Balchem Corp's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability

Balchem Corp has an operating margin of 20.2%, meaning the company retains $20 of operating profit per $100 of revenue. This strong profitability earns a score of 87/100, reflecting efficient cost management and pricing power. This is up from 19.2% the prior year.

Growth

Balchem Corp's revenue grew 8.8% year-over-year to $1.0B, a solid pace of expansion. This earns a growth score of 55/100.

Leverage

Balchem Corp carries a low D/E ratio of 0.34, meaning only $0.34 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 67/100, indicating a strong balance sheet with room for future borrowing.

Liquidity

Balchem Corp's current ratio of 2.07 indicates adequate short-term liquidity, earning a score of 59/100. The company can meet its near-term obligations, though with limited headroom.

Cash Flow

Not available for Balchem Corp, and counted as zero in the overall score.

Returns

Balchem Corp earns a strong 12.3% return on equity (ROE), meaning it generates $12 of profit for every $100 of shareholders' equity. This efficient capital use earns a returns score of 81/100. This is up from 11.2% the prior year.

Altman Z-Score Safe

10.05

Balchem Corp scores 10.05, well above the 2.99 safe threshold. The score is driven primarily by a large market capitalization ($5.7B) relative to total liabilities ($428.8M). This indicates low bankruptcy risk based on profitability, leverage, and asset efficiency.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Partial

8/8

Balchem Corp passes 8 of 8 computable financial strength tests (1 of the nine could not be computed from available data). All 4 profitability signals pass (positive income, cash flow, and earnings quality), all 2 leverage/liquidity signals pass, both operating efficiency signals pass.

Earnings Quality Cash-Backed

1.40x

For every $1 of reported earnings, Balchem Corp generates $1.40 in operating cash flow ($216.6M OCF vs $154.8M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$1.0B

YoY+8.8%

5Y CAGR+8.1%

10Y CAGR+6.5%

Balchem Corp generated $1.0B in revenue in fiscal year 2025. This represents an increase of 8.8% from the prior year.

EBITDA

$255.0M

YoY+10.5%

5Y CAGR+9.4%

10Y CAGR+6.7%

Balchem Corp's EBITDA was $255.0M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 10.5% from the prior year.

Net Income

$154.8M

YoY+20.5%

5Y CAGR+12.8%

10Y CAGR+10.0%

Balchem Corp reported $154.8M in net income in fiscal year 2025. This represents an increase of 20.5% from the prior year.

EPS (Diluted)

$4.75

YoY+20.9%

5Y CAGR+12.8%

10Y CAGR+9.7%

Balchem Corp earned $4.75 per diluted share (EPS) in fiscal year 2025. This represents an increase of 20.9% from the prior year.

Cash & Balance Sheet

Cash & Debt

$74.6M

YoY+50.6%

5Y CAGR-2.5%

10Y CAGR-1.3%

Balchem Corp held $74.6M in cash as of fiscal year 2025; long-term debt is not reported for that period.

Dividends Per Share

$0.96

YoY+10.3%

Balchem Corp paid $0.96 per share in dividends in fiscal year 2025. This represents an increase of 10.3% from the prior year.

Shares Outstanding

32M

YoY-1.6%

5Y CAGR-0.2%

10Y CAGR+0.2%

Balchem Corp had 32M shares outstanding in fiscal year 2025. This represents a decrease of 1.6% from the prior year.

Free Cash Flow

Not reported for fiscal year 2025.

Margins & Returns

Gross Margin

35.7%

YoY+0.5pp

5Y CAGR+3.9pp

10Y CAGR+5.3pp

Balchem Corp's gross margin was 35.7% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is up 0.5 percentage points from the prior year.

Operating Margin

20.2%

YoY+1.0pp

5Y CAGR+4.4pp

10Y CAGR+3.2pp

Balchem Corp's operating margin was 20.2% in fiscal year 2025, reflecting core business profitability. This is up 1.0 percentage points from the prior year.

Net Margin

14.9%

YoY+1.5pp

5Y CAGR+2.9pp

10Y CAGR+4.1pp

Balchem Corp's net profit margin was 14.9% in fiscal year 2025, showing the share of revenue converted to profit. This is up 1.5 percentage points from the prior year.

Return on Equity

12.3%

YoY+1.1pp

5Y CAGR+2.1pp

10Y CAGR-0.6pp

Balchem Corp's ROE was 12.3% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is up 1.1 percentage points from the prior year.

Capital Allocation

R&D Spending

$18.5M

YoY+10.2%

5Y CAGR+12.4%

10Y CAGR+11.9%

Balchem Corp invested $18.5M in research and development in fiscal year 2025. This represents an increase of 10.2% from the prior year.

Share Buybacks

$107.6M

YoY+1794.3%

5Y CAGR+51.6%

10Y CAGR+56.7%

Balchem Corp spent $107.6M on share buybacks in fiscal year 2025, returning capital to shareholders by reducing shares outstanding. This represents an increase of 1794.3% from the prior year.

Capital Expenditures

Not reported for fiscal year 2025.

BCPC Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

BCPC quarterly income statement

Metric	TTM	FY25	FY24	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11
Revenue	$1.1B	$1.0B+8.8%	$953.7M+3.4%	$922.4M-2.1%	$942.4M+17.9%	$799.0M+13.6%	$703.6M+9.3%	$643.7M0.0%	$643.7M+8.2%	$594.8M+7.5%	$553.2M+0.1%	$552.5M+2.1%	$541.4M+60.6%	$337.2M+8.6%	$310.4M+6.3%	$291.9M
Cost of Revenue	N/A	$666.5M+7.9%	$617.5M-0.5%	$620.4M-6.3%	$661.9M+19.1%	$555.8M+15.9%	$479.7M+11.0%	$432.3M-1.6%	$439.4M+8.3%	$405.8M+9.0%	$372.3M-3.1%	$384.4M-3.2%	$397.2M+65.7%	$239.8M+8.6%	$220.9M+7.3%	$205.9M
Gross Profit	$394.1M	$370.6M+10.2%	$336.2M+11.3%	$302.1M+7.7%	$280.5M+15.3%	$243.2M+8.6%	$223.9M+5.9%	$211.4M+3.5%	$204.3M+8.1%	$189.0M+4.5%	$180.9M+7.6%	$168.1M+16.6%	$144.2M+48.0%	$97.4M+8.8%	$89.5M+4.1%	$86.0M
R&D Expenses	N/A	$18.5M+10.2%	$16.8M+11.6%	$15.0M+23.4%	$12.2M-9.9%	$13.5M+30.9%	$10.3M-9.2%	$11.4M-1.9%	$11.6M+24.6%	$9.3M+27.0%	$7.3M+22.3%	$6.0M+24.5%	$4.8M+32.8%	$3.6M+5.8%	$3.4M+18.4%	$2.9M
SG&A Expenses	N/A	$67.4M-0.2%	$67.6M+26.5%	$53.4M-4.0%	$55.7M+33.4%	$41.7M-4.7%	$43.8M+20.0%	$36.5M+28.8%	$28.3M+0.9%	$28.1M+2.0%	$27.5M+849.2%	$2.9M0.0%	$2.9M-76.4%	$12.3M+18.0%	$10.4M-1.8%	$10.6M
Operating Income	N/A	$209.3M+14.4%	$182.9M+14.9%	$159.2M+9.6%	$145.2M+13.9%	$127.5M+14.7%	$111.1M+8.4%	$102.6M-4.2%	$107.1M+10.5%	$96.9M+6.7%	$90.8M-3.3%	$94.0M+14.4%	$82.1M+25.2%	$65.6M+9.7%	$59.8M+6.3%	$56.2M
Interest Expense	N/A	N/A	N/A	-$22.6M-120.2%	-$10.3M-318.1%	-$2.5M+44.7%	-$4.4M+25.5%	-$6.0M+21.7%	-$7.6M-200.9%	$7.5M+3.8%	$7.3M+10.2%	$6.6M+28.1%	$5.1M+21337.5%	$24K+140.0%	$10K-88.1%	$84K
Income Tax	N/A	$44.2M+16.3%	$38.0M+32.2%	$28.7M+1.2%	$28.4M-2.6%	$29.1M+33.7%	$21.8M+29.7%	$16.8M-17.8%	$20.5M+1392.3%	-$1.6M-105.9%	$27.0M-1.4%	$27.3M+12.9%	$24.2M+15.7%	$20.9M+5.6%	$19.8M+10.4%	$18.0M
Net Income	$164.4M	$154.8M+20.5%	$128.5M+18.4%	$108.5M+3.0%	$105.4M+9.6%	$96.1M+13.6%	$84.6M+6.2%	$79.7M+1.4%	$78.6M-12.8%	$90.1M+60.9%	$56.0M-6.3%	$59.7M+13.1%	$52.8M+17.7%	$44.9M+12.2%	$40.0M+3.2%	$38.8M
EPS (Diluted)	$5.09	$4.75+20.9%	$3.93+17.3%	$3.35+3.1%	$3.25+10.5%	$2.94+13.1%	$2.60+6.1%	$2.45+1.2%	$2.42-13.3%	$2.79+59.4%	$1.75-7.4%	$1.89+11.8%	$1.69+16.6%	$1.45+9.8%	$1.32+3.1%	$1.28

Metric	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24
Revenue	$284.0M+4.9%	$270.7M+2.7%	$263.6M-1.5%	$267.6M+4.7%	$255.5M+2.0%	$250.5M+4.4%	$240.0M0.0%	$239.9M
Cost of Revenue	$180.3M+6.3%	$169.6M	N/A	$172.1M+6.0%	$162.4M0.0%	$162.4M	N/A	$154.6M
Gross Profit	$103.7M+2.6%	$101.1M+7.7%	$93.9M-1.6%	$95.5M+2.5%	$93.1M+5.6%	$88.2M+2.1%	$86.3M+1.1%	$85.4M
R&D Expenses	$4.5M-22.9%	$5.9M	N/A	$4.5M+4.6%	$4.3M-7.8%	$4.7M	N/A	$4.3M
SG&A Expenses	$18.8M+1.7%	$18.5M	N/A	$17.3M-4.3%	$18.1M+16.1%	$15.6M	N/A	$17.5M
Operating Income	$59.2M+6.5%	$55.6M	N/A	$54.6M+6.1%	$51.4M+0.8%	$51.0M	N/A	$48.0M
Income Tax	$13.2M+7.6%	$12.2M	N/A	$11.8M+9.5%	$10.7M-1.4%	$10.9M	N/A	$10.1M
Net Income	$44.6M+10.7%	$40.3M+2.7%	$39.2M-2.6%	$40.3M+5.3%	$38.3M+3.3%	$37.1M+10.3%	$33.6M-0.8%	$33.8M
EPS (Diluted)	$1.39+11.2%	$1.25+3.3%	$1.21-2.4%	$1.24+6.0%	$1.17+3.5%	$1.13+9.7%	$1.030.0%	$1.03

Not reported in any period shown, so not listed: Interest Expense.

BCPC Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

BCPC quarterly balance sheet

Metric	FY25	FY24	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11
Total Assets	$1.7B+7.0%	$1.6B-1.4%	$1.6B-1.7%	$1.6B+35.5%	$1.2B+2.9%	$1.2B+0.9%	$1.2B+17.8%	$981.4M+1.8%	$963.6M+1.6%	$948.6M+7.8%	$879.7M+2.1%	$861.5M+128.6%	$376.9M+20.6%	$312.5M+15.0%	$271.7M
Current Assets	$365.6M+16.5%	$313.8M-0.2%	$314.2M-6.4%	$335.8M+4.2%	$322.2M+20.7%	$266.9M+4.7%	$254.9M+12.7%	$226.3M+13.5%	$199.3M+5.8%	$188.4M-5.0%	$198.3M+9.4%	$181.3M-34.7%	$277.8M+31.1%	$211.9M+20.6%	$175.7M
Cash & Equivalents	$74.6M+50.6%	$49.5M-23.2%	$64.4M-3.2%	$66.6M-35.5%	$103.2M+22.1%	$84.6M+28.8%	$65.7M+21.0%	$54.3M+34.3%	$40.4M+4.6%	$38.6M-54.4%	$84.8M+68.6%	$50.3M-75.9%	$208.7M+44.2%	$144.7M+26.1%	$114.8M
Inventory	$131.4M+0.5%	$130.8M+19.4%	$109.5M-8.5%	$119.7M+31.4%	$91.1M+28.9%	$70.6M-15.8%	$83.9M+24.9%	$67.2M+10.7%	$60.7M+6.0%	$57.2M+24.2%	$46.1M-7.1%	$49.6M+99.9%	$24.8M+20.0%	$20.7M+11.0%	$18.6M
Accounts Receivable	$143.6M+20.0%	$119.7M-4.5%	$125.3M-4.8%	$131.6M+12.1%	$117.4M+19.5%	$98.2M+5.1%	$93.4M-6.1%	$99.5M+9.1%	$91.2M+9.6%	$83.3M+37.6%	$60.5M-16.0%	$72.0M+82.8%	$39.4M-6.2%	$42.0M+22.0%	$34.4M
Goodwill	$816.4M+4.7%	$780.0M+0.1%	$778.9M+1.2%	$769.5M+46.9%	$523.9M-1.0%	$529.5M+1.0%	$524.0M+17.0%	$448.0M+1.5%	$441.4M+0.4%	$439.8M+14.6%	$383.9M0.0%	$383.9M+1246.3%	$28.5M0.0%	$28.5M0.0%	$28.5M
Total Liabilities	$428.8M+0.8%	$425.5M-21.7%	$543.2M-20.8%	$686.2M+112.9%	$322.3M-4.5%	$337.6M-18.1%	$412.0M+42.2%	$289.7M-16.4%	$346.8M-18.9%	$427.6M+2.8%	$416.0M-11.4%	$469.6M+931.8%	$45.5M+15.1%	$39.5M-0.4%	$39.7M
Current Liabilities	$176.4M+11.9%	$157.7M+6.2%	$148.5M+6.0%	$140.0M-2.6%	$143.8M+52.3%	$94.4M+2.4%	$92.3M+12.4%	$82.1M-24.3%	$108.4M+7.3%	$101.0M+24.5%	$81.1M-15.1%	$95.5M+167.2%	$35.8M+18.3%	$30.2M-2.2%	$30.9M
Long-Term Debt	N/A	N/A	N/A	N/A	N/A	N/A	N/A	$156.0M	N/A	$226.5M-13.2%	$261.0M-12.3%	$297.5M	$0	$0-100.0%	$23K
Total Equity	$1.3B+9.3%	$1.1B+9.1%	$1.1B+12.3%	$938.3M+7.0%	$877.0M+5.9%	$828.2M+11.4%	$743.7M+7.5%	$691.6M+12.1%	$616.9M+18.4%	$521.0M+12.4%	$463.7M+18.3%	$391.9M+18.3%	$331.4M+21.4%	$273.0M+17.7%	$232.0M
Retained Earnings	$1.1B+12.4%	$997.5M+11.1%	$897.5M+10.2%	$814.5M+11.2%	$732.1M+11.5%	$656.7M+11.1%	$590.9M+11.9%	$528.0M+13.6%	$464.6M+19.7%	$388.1M+12.8%	$344.2M+16.6%	$295.2M+17.3%	$251.6M+17.2%	$214.6M+18.5%	$181.1M

Metric	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24
Total Assets	$1.7B-0.4%	$1.7B+0.4%	$1.7B+1.5%	$1.7B-1.0%	$1.7B+3.8%	$1.6B+2.7%	$1.6B-1.4%	$1.6B
Current Assets	$388.4M-0.1%	$388.9M+6.4%	$365.6M+6.4%	$343.7M-5.8%	$364.9M+7.2%	$340.2M+8.4%	$313.8M-3.7%	$326.0M
Cash & Equivalents	$63.2M-13.3%	$72.9M-2.3%	$74.6M+14.6%	$65.1M-0.5%	$65.4M+31.1%	$49.9M+0.8%	$49.5M-32.8%	$73.7M
Inventory	$161.6M+10.1%	$146.7M+11.6%	$131.4M-0.7%	$132.4M-10.6%	$148.2M+2.2%	$144.9M+10.8%	$130.8M+10.4%	$118.5M
Accounts Receivable	$149.0M-3.4%	$154.2M+7.4%	$143.6M+9.2%	$131.5M-3.3%	$136.0M+4.2%	$130.4M+9.0%	$119.7M-0.7%	$120.5M
Goodwill	$808.8M-0.3%	$811.5M-0.6%	$816.4M0.0%	$816.5M0.0%	$816.4M+2.9%	$793.1M+1.7%	$780.0M-0.1%	$781.1M
Total Liabilities	$384.6M-5.9%	$408.6M-4.7%	$428.8M+18.1%	$363.2M-11.5%	$410.3M+0.4%	$408.9M-3.9%	$425.5M+1.4%	$419.7M
Current Liabilities	$145.8M-4.4%	$152.5M-13.5%	$176.4M+39.6%	$126.4M-8.5%	$138.1M-1.0%	$139.6M-11.5%	$157.7M+44.1%	$109.4M
Total Equity	$1.3B+1.3%	$1.3B+2.2%	$1.3B-3.1%	$1.3B+2.4%	$1.3B+4.9%	$1.2B+5.1%	$1.1B-2.3%	$1.2B
Retained Earnings	$1.2B+3.8%	$1.2B+3.6%	$1.1B+0.7%	$1.1B+3.8%	$1.1B+3.7%	$1.0B+3.7%	$997.5M+0.5%	$992.4M

Not reported in any period shown, so not listed: Long-Term Debt.

BCPC Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

BCPC quarterly cash flow statement

Metric	TTM	FY25	FY24	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11
Operating Cash Flow	$219.6M	$216.6M+19.0%	$182.0M-1.0%	$183.8M+32.6%	$138.5M-13.7%	$160.5M+6.7%	$150.5M+20.9%	$124.5M+4.9%	$118.7M+7.3%	$110.6M+2.8%	$107.6M+3.6%	$103.8M+21.6%	$85.3M+53.3%	$55.7M+3.6%	$53.8M+19.8%	$44.9M
Capital Expenditures	N/A	N/A	N/A	N/A	$49.1M+35.8%	$36.1M+12.7%	$32.1M+24.4%	$25.8M+34.5%	$19.2M-30.4%	$27.5M+19.5%	$23.0M-44.2%	$41.3M+212.9%	$13.2M+61.2%	$8.2M-41.0%	$13.9M+110.0%	$6.6M
Free Cash Flow	N/A	N/A	N/A	N/A	$89.5M-28.1%	$124.4M+5.0%	$118.4M+20.0%	$98.7M-0.9%	$99.5M+19.8%	$83.1M-1.8%	$84.6M+35.3%	$62.5M-13.3%	$72.2M+51.9%	$47.5M+19.1%	$39.9M+4.2%	$38.3M
Investing Cash Flow	-$48.6M	-$43.9M+26.5%	-$59.7M-71.6%	-$34.8M+91.6%	-$416.0M-1078.5%	-$35.3M-2.0%	-$34.6M+77.9%	-$156.2M-388.3%	-$32.0M+25.1%	-$42.7M+68.0%	-$133.6M-216.0%	-$42.3M	N/A	-$8.4M+40.2%	-$14.0M-111.9%	-$6.6M
Financing Cash Flow	-$171.7M	-$152.8M-14.2%	-$133.8M+12.7%	-$153.3M-162.2%	$246.7M+341.4%	-$102.2M-1.0%	-$101.2M-333.2%	$43.4M+160.7%	-$71.4M-4.1%	-$68.6M-252.8%	-$19.5M+24.7%	-$25.8M	N/A	$16.5M+267.3%	-$9.8M-1457.4%	-$632K
Dividends Paid	$30.8M	$28.3M+10.6%	$25.6M+11.8%	$22.9M+10.4%	$20.7M+10.6%	$18.7M+12.1%	$16.7M+10.4%	$15.1M+12.7%	$13.4M+11.3%	$12.1M+12.6%	$10.7M+15.9%	$9.3M+17.8%	$7.9M	$0-100.0%	$11.7M+171.5%	$4.3M
Share Buybacks	$113.5M	$107.6M+1794.3%	$5.7M+27.1%	$4.5M-87.4%	$35.4M+0.5%	$35.2M+161.7%	$13.5M-36.9%	$21.3M+1429.5%	$1.4M-26.8%	$1.9M+20.0%	$1.6M+31.8%	$1.2M+12.8%	$1.1M-44.5%	$1.9M+13.3%	$1.7M+1458.7%	$109K

Metric	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24
Operating Cash Flow	$46.7M+16.6%	$40.1M-40.5%	$67.3M+2.6%	$65.6M+38.8%	$47.3M+29.6%	$36.5M-30.3%	$52.3M+2.0%	$51.3M
Investing Cash Flow	-$10.9M-73.8%	-$6.3M+61.7%	-$16.4M-9.9%	-$14.9M-125.7%	-$6.6M-12.0%	-$5.9M+84.0%	-$37.0M-302.6%	-$9.2M
Financing Cash Flow	-$44.8M-28.9%	-$34.8M+15.7%	-$41.2M+18.9%	-$50.8M-76.7%	-$28.8M+10.0%	-$32.0M+9.2%	-$35.2M-2.4%	-$34.4M
Dividends Paid	$3K-100.0%	$30.8M+279618.2%	$11K0.0%	$11K+450.0%	$2K-100.0%	$28.3M+706475.0%	$4K0.0%	$4K
Share Buybacks	$28.8M+83.5%	$15.7M-70.7%	$53.6M+247.8%	$15.4M-53.6%	$33.3M+524.7%	$5.3M+1640.2%	$306K+87.7%	$163K

Not reported in any period shown, so not listed: Capital Expenditures, Free Cash Flow.

BCPC Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples.

BCPC quarterly financial ratios

Metric	FY25	FY24	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11
Gross Margin	35.7%+0.5pp	35.3%+2.5pp	32.8%+3.0pp	29.8%-0.7pp	30.4%-1.4pp	31.8%-1.0pp	32.8%+1.1pp	31.7%-0.1pp	31.8%-0.9pp	32.7%+2.3pp	30.4%+3.8pp	26.6%-2.3pp	28.9%0.0pp	28.8%-0.6pp	29.5%
Operating Margin	20.2%+1.0pp	19.2%+1.9pp	17.3%+1.9pp	15.4%-0.6pp	16.0%+0.2pp	15.8%-0.1pp	15.9%-0.7pp	16.6%+0.4pp	16.3%-0.1pp	16.4%-0.6pp	17.0%+1.8pp	15.2%-4.3pp	19.5%+0.2pp	19.3%0.0pp	19.3%
Net Margin	14.9%+1.5pp	13.5%+1.7pp	11.8%+0.6pp	11.2%-0.9pp	12.0%0.0pp	12.0%-0.3pp	12.4%+0.2pp	12.2%-2.9pp	15.1%+5.0pp	10.1%-0.7pp	10.8%+1.0pp	9.8%-3.5pp	13.3%+0.4pp	12.9%-0.4pp	13.3%
Return on Equity	12.3%+1.1pp	11.2%+0.9pp	10.3%-0.9pp	11.2%+0.3pp	11.0%+0.7pp	10.2%-0.5pp	10.7%-0.7pp	11.4%-3.2pp	14.6%+3.9pp	10.7%-2.1pp	12.9%-0.6pp	13.5%-0.1pp	13.5%-1.1pp	14.6%-2.1pp	16.7%
Return on Assets	9.2%+1.0pp	8.2%+1.4pp	6.8%+0.3pp	6.5%-1.5pp	8.0%+0.8pp	7.3%+0.4pp	6.9%-1.1pp	8.0%-1.3pp	9.3%+3.5pp	5.9%-0.9pp	6.8%+0.7pp	6.1%-5.8pp	11.9%-0.9pp	12.8%-1.5pp	14.3%
Current Ratio	2.07+0.1x	1.99-0.1x	2.12-0.3x	2.40+0.2x	2.24-0.6x	2.83+0.1x	2.760.0x	2.76+0.9x	1.840.0x	1.87-0.6x	2.44+0.5x	1.90-5.9x	7.77+0.8x	7.01+1.3x	5.68
Debt-to-Equity	0.340.0x	0.37-0.1x	0.52-0.2x	0.73+0.4x	0.370.0x	0.41-0.1x	0.55+0.3x	0.23-0.3x	0.56+0.1x	0.43-0.1x	0.56-0.2x	0.76+0.8x	0.000.0x	0.000.0x	0.00
FCF Margin	N/A	N/A	N/A	9.5%-6.1pp	15.6%-1.3pp	16.8%+1.5pp	15.3%-0.1pp	15.5%+1.5pp	14.0%-1.3pp	15.3%+4.0pp	11.3%-2.0pp	13.3%-0.8pp	14.1%+1.2pp	12.8%-0.3pp	13.1%

Metric	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24
Gross Margin	36.5%-0.8pp	37.3%+1.7pp	35.6%-0.1pp	35.7%-0.8pp	36.4%+1.3pp	35.2%-0.8pp	36.0%+0.4pp	35.6%
Operating Margin	20.8%+0.3pp	20.5%	N/A	20.4%+0.3pp	20.1%-0.2pp	20.4%	N/A	20.0%
Net Margin	15.7%+0.8pp	14.9%0.0pp	14.9%-0.2pp	15.1%+0.1pp	15.0%+0.2pp	14.8%+0.8pp	14.0%-0.1pp	14.1%
Return on Equity	3.4%+0.3pp	3.1%0.0pp	3.1%0.0pp	3.1%+0.1pp	3.0%-0.1pp	3.1%+0.2pp	2.9%+0.1pp	2.9%
Return on Assets	2.6%+0.3pp	2.4%+0.1pp	2.3%-0.1pp	2.4%+0.1pp	2.3%0.0pp	2.3%+0.2pp	2.1%0.0pp	2.1%
Current Ratio	2.66+0.1x	2.55+0.5x	2.07-0.6x	2.72+0.1x	2.64+0.2x	2.44+0.4x	1.99-1.0x	2.98
Debt-to-Equity	0.300.0x	0.320.0x	0.34+0.1x	0.280.0x	0.320.0x	0.340.0x	0.370.0x	0.36

Not reported in any period shown, so not listed: FCF Margin.

Similar Companies

Sensient Tech SXT

$5.7B

Cabot CBT

$4.4B

Element Solutions Inc ESI

$8.9B

Sasol SSL

$7.4B

Axalta Coating Sys Ltd AXTA

$7.9B

Where Balchem Corp Ranks

Frequently Asked Questions

What is Balchem Corp's annual revenue?

Balchem Corp (BCPC) reported $1.0B in total revenue for fiscal year 2025. This represents a 8.8% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Balchem Corp's revenue growing?

Balchem Corp (BCPC) revenue grew by 8.8% year-over-year, from $953.7M to $1.0B in fiscal year 2025.

Is Balchem Corp profitable?

Yes, Balchem Corp (BCPC) reported a net income of $154.8M in fiscal year 2025, with a net profit margin of 14.9%.

What is Balchem Corp's EBITDA?

Balchem Corp (BCPC) had EBITDA of $255.0M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

What is Balchem Corp's gross margin?

Balchem Corp (BCPC) had a gross margin of 35.7% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

What is Balchem Corp's operating margin?

Balchem Corp (BCPC) had an operating margin of 20.2% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

What is Balchem Corp's net profit margin?

Balchem Corp (BCPC) had a net profit margin of 14.9% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Does Balchem Corp pay dividends?

Yes, Balchem Corp (BCPC) paid $0.96 per share in dividends during fiscal year 2025.

What is Balchem Corp's return on equity (ROE)?

Balchem Corp (BCPC) has a return on equity of 12.3% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is Balchem Corp's operating cash flow?

Balchem Corp (BCPC) generated $216.6M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are Balchem Corp's total assets?

Balchem Corp (BCPC) had $1.7B in total assets as of fiscal year 2025, including both current and long-term assets.

How much does Balchem Corp spend on research and development?

Balchem Corp (BCPC) invested $18.5M in research and development during fiscal year 2025.

Does Balchem Corp buy back shares?

Yes, Balchem Corp (BCPC) spent $107.6M on share buybacks during fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

How many shares does Balchem Corp have outstanding?

Balchem Corp (BCPC) had 32M shares outstanding as of fiscal year 2025.

What is Balchem Corp's current ratio?

Balchem Corp (BCPC) had a current ratio of 2.07 as of fiscal year 2025, which is generally considered healthy.

What is Balchem Corp's debt-to-equity ratio?

Balchem Corp (BCPC) had a debt-to-equity ratio of 0.34 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Balchem Corp's return on assets (ROA)?

Balchem Corp (BCPC) had a return on assets of 9.2% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is Balchem Corp's Altman Z-Score?

Balchem Corp (BCPC) has an Altman Z-Score of 10.05, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

What is Balchem Corp's Piotroski F-Score?

Balchem Corp (BCPC) has a Piotroski F-Score of 8 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Balchem Corp's earnings high quality?

Balchem Corp (BCPC) has an earnings quality ratio of 1.40x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

How financially healthy is Balchem Corp?

Balchem Corp (BCPC) scores 58 out of 100 on our Financial Health Score, indicating moderate standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.